FE 999904

Drug Profile

FE 999904

Alternative Names: FE 999 904; HP hCG; Human chorionic gonadotropin - Ferring Pharmaceuticals

Latest Information Update: 26 Mar 2009

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Ferring Pharmaceuticals
  • Class Infertility therapies; Peptide hormones; Pituitary gonadotropins
  • Mechanism of Action Chorionic gonadotropin stimulants; Ovarian follicle stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Female infertility

Most Recent Events

  • 26 Mar 2009 No development reported - Phase-I for Female infertility in USA (unspecified route)
  • 08 Nov 2006 Phase I development is ongoing for Female infertility
  • 14 Oct 2004 Phase-I clinical trials in Female infertility in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top